• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Hookipa Pharma Inc (NQ: HOOK )

    3.570 -0.130 (-3.52%)
    Streaming Delayed Price Updated: 3:16 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Hookipa Pharma Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers HOOKIPA Pharma (NASDAQ:HOOK) stoc... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 27.0% to $2.54 during Friday's regular session. The current volume of 40.0 million shares is 1123.6% of... 
    Via Benzinga
    25 Stocks Moving in Thursday's Pre-Market Session
    Gainers DoorDash, Inc. (NYSE: DASH) rose 24.3% to $117.94 in pre-market trading after the company reported better-than-expected Q4 sales results. Marin Software Incorporated... 
    Via Benzinga
    Mid-Afternoon Market Update: US Stocks Pare Losses; S&P 500 Turns Higher
    US stocks pared losses toward the end of trading on Wednesday following the release of Fed minutes. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
    Via Benzinga
    56 Biggest Movers From Yesterday
    Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
    Via Benzinga
    Mid-Day Market Update: Crude Oil Rises 2%; EIA Reports Unexpected Rise In Crude Inventories
    US stocks traded lower midway through trading on Wednesday ahead of the release of Fed minutes. 
    Via Benzinga
    40 Stocks Moving In Wednesday's Mid-Day Session
    Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral... 
    Via Benzinga
    Hookipa Pharma Stock Surges On HIV Pact With Gilead
    Hookipa Pharma Inc (NASDAQ: HOOK) amended and restated collaboration and license agreement with Gilead Sciences Inc (NASDAQ: GILD) for arenaviral... 
    Via Benzinga
    The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
    Via Benzinga
    23 Stocks Moving in Wednesday's Pre-Market Session
    Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) rose 41.8% to $1.90 in pre-market trading after the company announced it entered into an amended and restated collaboration... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Syros Pharmaceuticals (NASDAQ:SYRS 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a... 
    Via Benzinga
    Stocks Hitting New 52-Week Lows Today
    On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 12, 2021
    Upgrades For Blink Charging Co (NASDAQ: 
    Via Benzinga
    What 5 Analyst Ratings Have To Say About HOOKIPA Pharma
    HOOKIPA Pharma (NASDAQ:HOOK) has observed the following analyst ratings wi... 
    Via Benzinga
    HOOKIPA Pharma's Return On Capital Employed Insights
    Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q3 sales of $3.87 million. Earnings fell to a loss of $21.17 million, resulting in a 9.73% decrease from last quarter.... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Seres Therapeutics (NASDAQ:MCRB) shares moved upwards by 31.29% to $9.02 during Wednesday's regular session. Trading volume for this security as of 12:30 EST... 
    Via Benzinga
    Preview: HOOKIPA Pharma's Earnings
    HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    Merus Stock Flirts With Breakout After Experimental Drug Shrinks All Tumors
    Merus is flirting with a buy point on its strong, early-stage cancer test results. 
    Via Investor's Business Daily
    The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
    Via Benzinga
    Exposures COVID-19
    Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial
    Hookipa Pharma Inc (NASDAQ: HOOK) has entered into a clinical collaboration and supply agreement with Merck & Co Inc (NYSE: MRK). The collaboration... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is... 
    Via Benzinga
    The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
    Via Benzinga
    The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... 
    Via Benzinga
    Exposures COVID-19
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.